Explains the bright yellow-green, almost-glowing urine that lands 1-2 hours after a B-complex, multivitamin, or standalone riboflavin dose — the most-photographed supplement side effect on the internet. Riboflavin (vitamin B2) is natively fluorescent (peak excitation ~450 nm, peak emission ~525 nm) — the same property that makes it useful as a tracer in pharmaceutical disintegration tests. Intestinal absorption is via the SLC52 family of riboflavin transporters (RFVT1/SLC52A1, RFVT2/SLC52A2, RFVT3/SLC52A3), characterized by Yonezawa 2008 and Yao 2010; the apical-side RFVT3 in enterocytes is the rate-limiting step and is saturable at modest single doses (Zempleni 1996 showed ~27 mg as the practical upper limit before disproportional excretion). Beyond that ceiling, unabsorbed riboflavin moves into stool while absorbed-but-unneeded riboflavin (above the tissue-storage requirement of ~1.3-1.6 mg/day) is filtered at the glomerulus and excreted in urine essentially unchanged, often within 1-2 hours — producing the characteristic fluorescent stream. The phenomenon is benign and a useful real-time marker of GI absorption: cloudy/lighter urine after a riboflavin-containing supplement suggests effective absorption-then-overflow; complete absence may signal severe absorption impairment. Color intensity scales with dose (visible at ~50 mg+ for most users), hydration state, and the time-since-dose; it fades within 4-6 hours. The yellow color of B-complex tablets and energy-drinks themselves is also riboflavin (E101).
Organ Systems
renal
digestive
Pathway Steps
riboflavin → intestinal absorption via RFVT3 (SLC52A3) — via apical enterocyte RFVT3 / RFVT1 / RFVT2 — facilitated transport, saturable at ~27 mg single dose (Zempleni 1996). Riboflavin (B2) is taken up by saturable RFVT transporters, so absorption caps per dose — large supplemental amounts are only partly absorbed. RFVT mutations cause Brown-Vialetto-Van Laere syndrome (riboflavin-responsive neuropathy).
intestinal absorption via RFVT3 (SLC52A3) → systemic FAD / FMN pool + tissue saturation — via absorbed riboflavin → FMN via riboflavin kinase → FAD; tissue holocoenzyme pools fill at ~1.3-1.6 mg/d. Absorbed riboflavin is converted by riboflavin kinase to FMN, then to FAD — the flavin cofactors for oxidoreductases (respiratory complexes I/II, fatty-acid oxidation, and the methylation enzyme MTHFR). Tissue flavin pools saturate at a ceiling.
systemic FAD / FMN pool + tissue saturation → free plasma riboflavin overflow — via beyond tissue-storage requirement, free riboflavin accumulates in plasma — basis of saturation kinetics. Once tissue cofactor needs are met, surplus riboflavin is not stored — it spills over as free vitamin into plasma, since the body keeps no meaningful B2 reserve (hence the need for regular intake).
free plasma riboflavin overflow → glomerular filtration + renal excretion — via low MW (376 Da), water-soluble, minimal protein binding → freely filtered; renal RFVT2/3 reabsorb to a ceiling. Free riboflavin (low MW ~376 Da, water-soluble, minimally protein-bound) is readily filtered and excreted — so high-dose B2 (and any B-complex/multivitamin) appears in urine within hours.
glomerular filtration + renal excretion → fluorescent yellow-green urine (peak emission ~525 nm) — via isoalloxazine ring fluoresces (peak ~525 nm) → bright yellow-green urine 1-2 h post-dose, fades by 4-6 h. Riboflavin’s isoalloxazine ring fluoresces (peak ~525 nm), turning urine bright neon yellow-green soon after a B-vitamin dose — a harmless, visible “flavinuria” that simply marks intake above tissue need.
Known Modulators
riboflavin (substrate) — RFVT3 (intestinal) + glomerular filtration → urine. the perpetrator — single doses ≥50 mg reliably produce visible neon-yellow urine; 5-25 mg typical B-complex still produces a more muted yellow shift; doses well above 27 mg face flat absorption (saturated RFVT3) so even very high doses don't change urinary brightness proportionally